IRIS
MINGARI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 38.527
AS - Asia 3.684
NA - Nord America 2.851
SA - Sud America 314
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 45.434
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 37.828
US - Stati Uniti d'America 2.658
SG - Singapore 1.570
CN - Cina 965
VN - Vietnam 603
FR - Francia 300
BR - Brasile 190
BD - Bangladesh 178
HK - Hong Kong 135
FI - Finlandia 126
CA - Canada 77
DE - Germania 77
AR - Argentina 57
JP - Giappone 51
CH - Svizzera 41
GB - Regno Unito 38
MX - Messico 32
IN - India 26
NL - Olanda 21
RU - Federazione Russa 21
ID - Indonesia 20
JM - Giamaica 20
IQ - Iraq 19
CO - Colombia 17
ZA - Sudafrica 14
HN - Honduras 13
PL - Polonia 13
CR - Costa Rica 12
PH - Filippine 12
SA - Arabia Saudita 12
VE - Venezuela 11
PK - Pakistan 10
CL - Cile 9
JO - Giordania 9
PY - Paraguay 9
TH - Thailandia 9
EC - Ecuador 8
ES - Italia 8
GT - Guatemala 8
IE - Irlanda 8
TW - Taiwan 8
BB - Barbados 7
DZ - Algeria 7
PE - Perù 7
UA - Ucraina 7
MA - Marocco 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
UZ - Uzbekistan 5
AO - Angola 4
AT - Austria 4
EG - Egitto 4
NI - Nicaragua 4
SE - Svezia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
CG - Congo 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KR - Corea 3
LT - Lituania 3
PR - Porto Rico 3
AL - Albania 2
BO - Bolivia 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
MK - Macedonia 2
MM - Myanmar 2
NG - Nigeria 2
OM - Oman 2
PS - Palestinian Territory 2
TN - Tunisia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DJ - Gibuti 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
Totale 45.413
Salva come PNG Salva come JPEG
Città #
Genova 24.564
Genoa 7.709
Rapallo 2.949
Vado Ligure 2.348
San Jose 807
Singapore 706
Ashburn 323
Lauterbourg 284
Ho Chi Minh City 178
Beijing 143
Hanoi 131
New York 129
Hong Kong 126
Helsinki 125
Council Bluffs 89
Santa Clara 87
Frankfurt am Main 60
Bordighera 52
Tokyo 50
Zurich 41
Los Angeles 40
Haiphong 35
Tianjin 29
Milan 27
Chicago 26
Atlanta 22
Shanghai 21
Phoenix 20
Houston 19
Orem 19
Rome 19
Da Nang 17
Mexico City 17
Buffalo 16
Dallas 16
São Paulo 16
Duarte 15
Biên Hòa 13
Toronto 13
Brooklyn 12
Amsterdam 11
Montreal 11
Des Moines 10
Hải Dương 10
Kingston 10
Las Vegas 10
Amman 9
Baghdad 9
Boardman 9
Columbus 9
Philadelphia 9
Chennai 8
City of London 8
Florence 8
Miami 8
Queens 8
Can Tho 7
Charlotte 7
Hưng Yên 7
Jacksonville 7
Johannesburg 7
Lima 7
London 7
Naples 7
Nuremberg 7
Paris 7
San José 7
Warsaw 7
Baltimore 6
Bridgetown 6
Cleveland 6
Curitiba 6
Denver 6
Dublin 6
Guangzhou 6
Ninh Bình 6
Phillipsburg 6
Thái Nguyên 6
Turin 6
Asunción 5
Bangkok 5
Bogotá 5
Boston 5
Cardiff 5
Detroit 5
Guatemala City 5
Hangzhou 5
Moscow 5
Nha Trang 5
Omaha 5
Pittsburgh 5
Poplar 5
Quận Ba 5
San Francisco 5
San Pedro Sula 5
Santiago 5
Shenyang 5
Shenzhen 5
Thái Bình 5
Boydton 4
Totale 41.714
Salva come PNG Salva come JPEG
Nome #
Mesenchymal stem cell-Natural Killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. 474
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 264
Identification of cytomegalovirus (CMV)-specific T lymphocytes displaying an effector-memory phenotype that kill CMV-infected target cells in an HLA-E-restricted fashion 260
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 243
Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy 230
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 228
Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein 224
Human NK cells at early stages of differentiation produce large amounts of CXCL8 and express CD161 molecule that that functions as an activating receptor 222
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function 219
Role of the calpain-calpastatin system in the density-dependent growth arrest 213
T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. 212
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 208
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation 207
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 200
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 198
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 197
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 196
Characterization of the calpain/calpastatin system in human hemopoietic cell lines 195
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 193
Effect of tumor cells and tumor microenvironment on NK-cell function. 193
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK cell function 192
Anticorpo ricombinante umano e suo uso per l’ identificazione del sindecano-1 a scopo diagnostico e terapeutico 192
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 192
Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression 191
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 190
IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors 190
NCR + ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures 188
Markers and function of human NK cells in normal and pathological conditions 186
CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. 185
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. 184
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 184
Human innate lymphoid cells 184
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 183
Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts 182
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells. 181
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 181
Evaluation of Glycosylated PTGS2 in Colorectal Cancer for NSAIDS-Based Adjuvant Therapy 181
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin. 179
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 179
"Physiological and Pathological Aspects of Human NK Cells" 178
Human NK receptors: from the molecules to the therapy of high risk leukemias. 178
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition 177
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 175
Characterization of human afferent lymph dendritic cells from seroma fluids. 175
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 174
Surface antigens specifically expressed by activated T cells in humans. 174
MSC and innate immune cell interactions: A lesson from human decidua 174
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 174
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 173
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 173
T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. 172
Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15. 172
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. 171
Stimulatory receptors in NK and T cells. 171
NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs 171
Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. 171
NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation 170
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition 170
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 169
Development of human natural killer cells and other innate lymphoid cells. 169
Analysis of the circulating Th1/Th17 lymphocyte repertoire after hematopoietic stem cell transplant may reveal opportunistic fungal infections rather than GvHD reaction 169
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph. 169
Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production 168
In vivo generation of decidual Natural Killer cells from resident hematopoietic progenitors. 168
Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells 168
Effect of superantigens on human thymocytes: selective proliferation of V beta 2+ cells in response to toxic shock syndrome toxin-1 and their deletion upon secondary stimulation 166
Surface receptors that regulate the NK cell function: beyond the NK cell scope. 166
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients 165
Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors. 165
IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid 164
Dendritic cells efficiently cross-prime HLA class I restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. 163
Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation 161
Il-1β-Releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from cd34+ precursors 161
Effect of tyrosin kinase inhibitors on NK Cell and ILC3 development and function 161
Comparative analysis of NK- or NK-CTL-mediated lysis of immature or mature autologous dendritic cells 159
Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients 159
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. 158
Surface markers of cloned human T cells with helper or suppressor activity on pokeweed mitogen-driven B cell differentiation. 158
Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: a regulated mechanism that controls T-cell activation and function. 157
Immunobiology of human NK cells. 157
Anticlonotypic monoclonal antibodies induce proliferation of clonotype-positive T cells in peripheral blood human T lymphocytes. Evidence for a phenotypic (T4/T8) heterogeneity of the clonotype-positive proliferating cells. 157
HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. 157
The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF 157
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells 157
Origin, phenotype and function of human natural killer cells in pregnancy. 156
Surface receptors and functional interactions of human natural killer cells: from bench to the clinic 156
Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation. 156
A conserved energetic footprint underpins recognition of Human Leukocyte Antigen-E by two distinct αβ T cell receptors 156
Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab 156
Analysis of the activating receptors and cytolytic function of human Natural Killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation 155
Human RORγt(+)CD34(+) Cells Are Lineage-Specified Progenitors of Group 3 RORγt(+) Innate Lymphoid Cells. 155
Immune response in the conjunctival epithelium of patients with dry eye. 154
Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens. 154
Unsung hero Robert C. Gallo 154
Expression of HLA-class I-specific inhibitory Natural Killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. 153
A new mechanism of resistance to NK cell attack in melanoma 153
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. 152
Distinctive lack of CD48 expression in subsets of human dendritic cells tunes NK cell activation. 152
Role of Ia Antigens in the human autologous mixed lymphocyte reaction. 151
Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells 151
Totale 18.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.535
article - articoli 137.427
book - libri 0
conference - conferenze 2.140
curatela - curatele 0
other - altro 0
patent - brevetti 783
selected - selezionate 0
volume - volumi 2.185
Totale 285.070
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.034 129 283 374 399 202 205 243 962 165 392 172 508
2022/20233.533 375 227 63 324 569 697 2 266 602 13 352 43
2023/20241.857 118 248 49 251 174 336 73 88 125 45 95 255
2024/20255.412 99 431 193 338 884 549 498 785 222 256 464 693
2025/20269.273 1.058 213 504 721 1.261 1.024 1.655 452 606 868 385 526
2026/2027831 831 0 0 0 0 0 0 0 0 0 0 0
Totale 45.902